Advanced or metastatic non-small-cell lung cancer treatment - new Polish goverment regulation
Journal Title: OncoReview - Year 2013, Vol 3, Issue 2
Abstract
The article presents the non-small-cell lung cancer current treatment recommendations in consideration of Polish government regulation.
Authors and Affiliations
Dariusz M. Kowalski, Paweł Krawczyk
Keywords
Related Articles
- EP ID EP53213
- DOI -
- Views 220
- Downloads 0
Pheochromocytoma and paraganglioma – an overview
Pheochromocytoma and paraganglioma derive from chromaffin tissue that secretes catecholamines, which determine the characteristic clinical picture of the disease. Serious and potentially fatal cardiovascular complication...
Changes in the gastrointestinal mucosa after radio- and chemotherapy of the neoplasms
Gastrointestinal mucositis induced by radio- and chemotherapy of the neoplasms is associated with morphological changes in the mucosa of the alimentary tract. The pain, ulceration, nausea, vomiting and diarrhea are the e...
Complications of palliative antiangiogenic therapy in patients with colorectal cancer
Introduction: Bevacizumab is an antiangiogenic drug used in the therapy of numerous solid tumours including colorectal adenocarcinoma. The efficacy and safety of bevacizumab has been demonstrated in many multicenter clin...
Targeted therapies for chronic myeloid leukemia and cardiovascular system
Morbidity of chronic myeloid leukemia is recorded in elderly population, in patients with coexisting significant risk factors for atherosclerosis and heart diseases. Molecularly targeted therapy, imatinib, dasatinib and...
Steroid-induced diabetes in oncology
Patients with neoplasms belong to the group of higher risk for developing steroid-induced diabetes. The rules of diagnosis of this form of diabetes do not differ from others of its type, but the course and treatment diff...